Research describes methodology for use of digital health technologies in Parkinson’s disease clinical trials

With 10 million people living with Parkinson’s worldwide, collaboration and data sharing are crucial for driving innovation in drug development for the fastest-growing degenerative neurological condition.

Leave A Comment

Your email address will not be published. Required fields are marked *